Director & Chief Executive Officer
Director & Chief Executive Officer at Mineralys Therapeutics, Inc., filing insider transactions between 2026-03-31 and 2026-06-30.
| SEC ↗ |
| 2026-03-31 | MLYS | Sale | 19.4K | $25.50 | $494K | SEC ↗ |
| 2026-03-31 | MLYS | Sale | 453 | $27.05 | $12K | SEC ↗ |
| 2026-03-31 | MLYS | Sale | 55.2K | $26.54 | $1.5M | SEC ↗ |